Drug response profiles in patient-derived cancer cells across histological subtypes of ovarian cancer: real-time therapy tailoring for a patient with low-grade serous carcinomaAstrid Murumägi, Olli Kallioniemi|British Journal of Cancer|2022Cited by 25